Global Pulmonary Function Testing Systems

Pulmonary Function Testing Systems Comprehensive Study by Type (Portable PFT Systems, Complete PFT Systems), Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease), Test (Spirometry, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing), Component (Software, Hardware, Services), End User (Hospital/Clinical Laboratories, Diagnostics Laboratories) Players and Region - Global Market Outlook to 2028

Pulmonary Function Testing Systems Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Pulmonary Function Testing Systems Market Scope
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function. The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.This report, the Pulmonary Function Testing Systems refer to the Pulmonary Function Testing Systems device, mainly covers the spirometer, pulmonary function/stress testing system, PFT, peak flow meter and other product type.



The global Pulmonary Function Testing Systems market including many local as well as regional players. Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Pulmonary Function Testing Systems market throughout the predicted period.

BD (United States), Schiller (Switzerland), COSMED (Italy), nSpire Health (United States), Morgan Scientific (United States), Vyaire Medical, Inc (United States), Medical Equipment Europe GmbH (Germany), ECO MEDICS AG (Switzerland) and CHEST M.I., Inc (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are MGC Diagnostics (United States) and Ganshorn (Germany).

Segmentation Overview
The study have segmented the market of Global Pulmonary Function Testing Systems market by Type (Portable PFT Systems and Complete PFT Systems), by Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath and Restrictive Lung Disease) and Region with country level break-up.

On the basis of geography, the market of Pulmonary Function Testing Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Growth Drivers:
Increasing Prevalence of Lung Cancer, Growth in the Elderly Population and Changing Life Style and Environmental Effects

Challenges:
Rising Cost of Pulmonary Devices

Restraints:
Stringent Regulatory Policies

Opportunities:
Increasing Scope Of High-Potency Pulmonary Function Testing and Increasing Healthcare Expenditure

Market Leaders and their Expansionary Development Strategies
In April 2018, Vyaire Medical Inc. plans to become a global leader in respiratory care, Vyaire Medical Inc. is a leader in respiratory care announced that it has acquired Acutronic Medical Systems and separately they entered into an agreement to acquire medical Ag, Inc
In October 2018, NSPIRE HEALTH INC. announced the introduction of Iris IQ. This technology removes incongruences between pulmonary function test results and other respiratory diagnostic exams., and In March 2018, COSMED srl announced the release of a new product line of metabolic monitors for quick, accurate, intuitive, and affordable indirect calorimetry.


Key Target Audience
Medical device manufacturers and distributors, Government research organizations, Hospitals and clinics, Regulatory agencies and Pharmaceutical companies

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Portable PFT Systems
  • Complete PFT Systems
By Application
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease
By Test
  • Spirometry
  • Lung Volume
  • Gas Exchange Testing
  • Maximal Voluntary Ventilation
  • Oxygen Titration Test
  • High Altitude Simulation Testing

By Component
  • Software
  • Hardware
  • Services

By End User
  • Hospital/Clinical Laboratories
  • Diagnostics Laboratories

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Lung Cancer
      • 3.2.2. Growth in the Elderly Population
      • 3.2.3. Changing Life Style and Environmental Effects
    • 3.3. Market Challenges
      • 3.3.1. Rising Cost of Pulmonary Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pulmonary Function Testing Systems, by Type, Application, Test, Component, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Pulmonary Function Testing Systems (Value)
      • 5.2.1. Global Pulmonary Function Testing Systems by: Type (Value)
        • 5.2.1.1. Portable PFT Systems
        • 5.2.1.2. Complete PFT Systems
      • 5.2.2. Global Pulmonary Function Testing Systems by: Application (Value)
        • 5.2.2.1. Chronic Obstructive Pulmonary Disease
        • 5.2.2.2. Asthma
        • 5.2.2.3. Chronic Shortness of Breath
        • 5.2.2.4. Restrictive Lung Disease
      • 5.2.3. Global Pulmonary Function Testing Systems by: Test (Value)
        • 5.2.3.1. Spirometry
        • 5.2.3.2. Lung Volume
        • 5.2.3.3. Gas Exchange Testing
        • 5.2.3.4. Maximal Voluntary Ventilation
        • 5.2.3.5. Oxygen Titration Test
        • 5.2.3.6. High Altitude Simulation Testing
      • 5.2.4. Global Pulmonary Function Testing Systems by: Component (Value)
        • 5.2.4.1. Software
        • 5.2.4.2. Hardware
        • 5.2.4.3. Services
      • 5.2.5. Global Pulmonary Function Testing Systems by: End User (Value)
        • 5.2.5.1. Hospital/Clinical Laboratories
        • 5.2.5.2. Diagnostics Laboratories
      • 5.2.6. Global Pulmonary Function Testing Systems Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Pulmonary Function Testing Systems (Price)
      • 5.3.1. Global Pulmonary Function Testing Systems by: Type (Price)
  • 6. Pulmonary Function Testing Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BD (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Schiller (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. COSMED (Italy)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. NSpire Health (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Morgan Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Vyaire Medical, Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medical Equipment Europe GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ECO MEDICS AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CHEST M.I., Inc (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Pulmonary Function Testing Systems Sale, by Type, Application, Test, Component, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Pulmonary Function Testing Systems (Value)
      • 7.2.1. Global Pulmonary Function Testing Systems by: Type (Value)
        • 7.2.1.1. Portable PFT Systems
        • 7.2.1.2. Complete PFT Systems
      • 7.2.2. Global Pulmonary Function Testing Systems by: Application (Value)
        • 7.2.2.1. Chronic Obstructive Pulmonary Disease
        • 7.2.2.2. Asthma
        • 7.2.2.3. Chronic Shortness of Breath
        • 7.2.2.4. Restrictive Lung Disease
      • 7.2.3. Global Pulmonary Function Testing Systems by: Test (Value)
        • 7.2.3.1. Spirometry
        • 7.2.3.2. Lung Volume
        • 7.2.3.3. Gas Exchange Testing
        • 7.2.3.4. Maximal Voluntary Ventilation
        • 7.2.3.5. Oxygen Titration Test
        • 7.2.3.6. High Altitude Simulation Testing
      • 7.2.4. Global Pulmonary Function Testing Systems by: Component (Value)
        • 7.2.4.1. Software
        • 7.2.4.2. Hardware
        • 7.2.4.3. Services
      • 7.2.5. Global Pulmonary Function Testing Systems by: End User (Value)
        • 7.2.5.1. Hospital/Clinical Laboratories
        • 7.2.5.2. Diagnostics Laboratories
      • 7.2.6. Global Pulmonary Function Testing Systems Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Pulmonary Function Testing Systems (Price)
      • 7.3.1. Global Pulmonary Function Testing Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pulmonary Function Testing Systems: by Type(USD Million)
  • Table 2. Pulmonary Function Testing Systems Portable PFT Systems , by Region USD Million (2017-2022)
  • Table 3. Pulmonary Function Testing Systems Complete PFT Systems , by Region USD Million (2017-2022)
  • Table 4. Pulmonary Function Testing Systems: by Application(USD Million)
  • Table 5. Pulmonary Function Testing Systems Chronic Obstructive Pulmonary Disease , by Region USD Million (2017-2022)
  • Table 6. Pulmonary Function Testing Systems Asthma , by Region USD Million (2017-2022)
  • Table 7. Pulmonary Function Testing Systems Chronic Shortness of Breath , by Region USD Million (2017-2022)
  • Table 8. Pulmonary Function Testing Systems Restrictive Lung Disease , by Region USD Million (2017-2022)
  • Table 9. Pulmonary Function Testing Systems: by Test(USD Million)
  • Table 10. Pulmonary Function Testing Systems Spirometry , by Region USD Million (2017-2022)
  • Table 11. Pulmonary Function Testing Systems Lung Volume , by Region USD Million (2017-2022)
  • Table 12. Pulmonary Function Testing Systems Gas Exchange Testing , by Region USD Million (2017-2022)
  • Table 13. Pulmonary Function Testing Systems Maximal Voluntary Ventilation , by Region USD Million (2017-2022)
  • Table 14. Pulmonary Function Testing Systems Oxygen Titration Test , by Region USD Million (2017-2022)
  • Table 15. Pulmonary Function Testing Systems High Altitude Simulation Testing , by Region USD Million (2017-2022)
  • Table 16. Pulmonary Function Testing Systems: by Component(USD Million)
  • Table 17. Pulmonary Function Testing Systems Software , by Region USD Million (2017-2022)
  • Table 18. Pulmonary Function Testing Systems Hardware , by Region USD Million (2017-2022)
  • Table 19. Pulmonary Function Testing Systems Services , by Region USD Million (2017-2022)
  • Table 20. Pulmonary Function Testing Systems: by End User(USD Million)
  • Table 21. Pulmonary Function Testing Systems Hospital/Clinical Laboratories , by Region USD Million (2017-2022)
  • Table 22. Pulmonary Function Testing Systems Diagnostics Laboratories , by Region USD Million (2017-2022)
  • Table 23. South America Pulmonary Function Testing Systems, by Country USD Million (2017-2022)
  • Table 24. South America Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 25. South America Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 26. South America Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 27. South America Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 28. South America Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 29. Brazil Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 30. Brazil Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 31. Brazil Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 32. Brazil Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 33. Brazil Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 34. Argentina Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 35. Argentina Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 36. Argentina Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 37. Argentina Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 38. Argentina Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 39. Rest of South America Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 40. Rest of South America Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 41. Rest of South America Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 42. Rest of South America Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 43. Rest of South America Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 44. Asia Pacific Pulmonary Function Testing Systems, by Country USD Million (2017-2022)
  • Table 45. Asia Pacific Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 46. Asia Pacific Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 47. Asia Pacific Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 48. Asia Pacific Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 49. Asia Pacific Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 50. China Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 51. China Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 52. China Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 53. China Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 54. China Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 55. Japan Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 56. Japan Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 57. Japan Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 58. Japan Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 59. Japan Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 60. India Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 61. India Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 62. India Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 63. India Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 64. India Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 65. South Korea Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 66. South Korea Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 67. South Korea Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 68. South Korea Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 69. South Korea Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 70. Taiwan Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 71. Taiwan Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 72. Taiwan Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 73. Taiwan Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 74. Taiwan Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 75. Australia Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 76. Australia Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 77. Australia Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 78. Australia Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 79. Australia Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 84. Rest of Asia-Pacific Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 85. Europe Pulmonary Function Testing Systems, by Country USD Million (2017-2022)
  • Table 86. Europe Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 87. Europe Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 88. Europe Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 89. Europe Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 90. Europe Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 91. Germany Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 92. Germany Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 93. Germany Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 94. Germany Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 95. Germany Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 96. France Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 97. France Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 98. France Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 99. France Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 100. France Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 101. Italy Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 102. Italy Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 103. Italy Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 104. Italy Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 105. Italy Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 106. United Kingdom Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 107. United Kingdom Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 108. United Kingdom Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 109. United Kingdom Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 110. United Kingdom Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 111. Netherlands Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 112. Netherlands Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 113. Netherlands Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 114. Netherlands Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 115. Netherlands Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 116. Rest of Europe Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 117. Rest of Europe Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 118. Rest of Europe Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 119. Rest of Europe Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 120. Rest of Europe Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 121. MEA Pulmonary Function Testing Systems, by Country USD Million (2017-2022)
  • Table 122. MEA Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 123. MEA Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 124. MEA Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 125. MEA Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 126. MEA Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 127. Middle East Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 128. Middle East Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 129. Middle East Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 130. Middle East Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 131. Middle East Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 132. Africa Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 133. Africa Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 134. Africa Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 135. Africa Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 136. Africa Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 137. North America Pulmonary Function Testing Systems, by Country USD Million (2017-2022)
  • Table 138. North America Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 139. North America Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 140. North America Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 141. North America Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 142. North America Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 143. United States Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 144. United States Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 145. United States Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 146. United States Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 147. United States Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 148. Canada Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 149. Canada Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 150. Canada Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 151. Canada Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 152. Canada Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 153. Mexico Pulmonary Function Testing Systems, by Type USD Million (2017-2022)
  • Table 154. Mexico Pulmonary Function Testing Systems, by Application USD Million (2017-2022)
  • Table 155. Mexico Pulmonary Function Testing Systems, by Test USD Million (2017-2022)
  • Table 156. Mexico Pulmonary Function Testing Systems, by Component USD Million (2017-2022)
  • Table 157. Mexico Pulmonary Function Testing Systems, by End User USD Million (2017-2022)
  • Table 158. Pulmonary Function Testing Systems: by Type(USD/Units)
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Pulmonary Function Testing Systems: by Type(USD Million)
  • Table 169. Pulmonary Function Testing Systems Portable PFT Systems , by Region USD Million (2023-2028)
  • Table 170. Pulmonary Function Testing Systems Complete PFT Systems , by Region USD Million (2023-2028)
  • Table 171. Pulmonary Function Testing Systems: by Application(USD Million)
  • Table 172. Pulmonary Function Testing Systems Chronic Obstructive Pulmonary Disease , by Region USD Million (2023-2028)
  • Table 173. Pulmonary Function Testing Systems Asthma , by Region USD Million (2023-2028)
  • Table 174. Pulmonary Function Testing Systems Chronic Shortness of Breath , by Region USD Million (2023-2028)
  • Table 175. Pulmonary Function Testing Systems Restrictive Lung Disease , by Region USD Million (2023-2028)
  • Table 176. Pulmonary Function Testing Systems: by Test(USD Million)
  • Table 177. Pulmonary Function Testing Systems Spirometry , by Region USD Million (2023-2028)
  • Table 178. Pulmonary Function Testing Systems Lung Volume , by Region USD Million (2023-2028)
  • Table 179. Pulmonary Function Testing Systems Gas Exchange Testing , by Region USD Million (2023-2028)
  • Table 180. Pulmonary Function Testing Systems Maximal Voluntary Ventilation , by Region USD Million (2023-2028)
  • Table 181. Pulmonary Function Testing Systems Oxygen Titration Test , by Region USD Million (2023-2028)
  • Table 182. Pulmonary Function Testing Systems High Altitude Simulation Testing , by Region USD Million (2023-2028)
  • Table 183. Pulmonary Function Testing Systems: by Component(USD Million)
  • Table 184. Pulmonary Function Testing Systems Software , by Region USD Million (2023-2028)
  • Table 185. Pulmonary Function Testing Systems Hardware , by Region USD Million (2023-2028)
  • Table 186. Pulmonary Function Testing Systems Services , by Region USD Million (2023-2028)
  • Table 187. Pulmonary Function Testing Systems: by End User(USD Million)
  • Table 188. Pulmonary Function Testing Systems Hospital/Clinical Laboratories , by Region USD Million (2023-2028)
  • Table 189. Pulmonary Function Testing Systems Diagnostics Laboratories , by Region USD Million (2023-2028)
  • Table 190. South America Pulmonary Function Testing Systems, by Country USD Million (2023-2028)
  • Table 191. South America Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 192. South America Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 193. South America Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 194. South America Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 195. South America Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 196. Brazil Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 197. Brazil Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 198. Brazil Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 199. Brazil Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 200. Brazil Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 201. Argentina Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 202. Argentina Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 203. Argentina Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 204. Argentina Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 205. Argentina Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 206. Rest of South America Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 207. Rest of South America Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 208. Rest of South America Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 209. Rest of South America Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 210. Rest of South America Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 211. Asia Pacific Pulmonary Function Testing Systems, by Country USD Million (2023-2028)
  • Table 212. Asia Pacific Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 213. Asia Pacific Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 214. Asia Pacific Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 215. Asia Pacific Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 216. Asia Pacific Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 217. China Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 218. China Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 219. China Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 220. China Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 221. China Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 222. Japan Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 223. Japan Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 224. Japan Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 225. Japan Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 226. Japan Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 227. India Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 228. India Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 229. India Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 230. India Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 231. India Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 232. South Korea Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 233. South Korea Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 234. South Korea Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 235. South Korea Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 236. South Korea Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 237. Taiwan Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 238. Taiwan Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 239. Taiwan Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 240. Taiwan Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 241. Taiwan Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 242. Australia Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 243. Australia Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 244. Australia Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 245. Australia Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 246. Australia Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 247. Rest of Asia-Pacific Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 248. Rest of Asia-Pacific Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 249. Rest of Asia-Pacific Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 250. Rest of Asia-Pacific Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 251. Rest of Asia-Pacific Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 252. Europe Pulmonary Function Testing Systems, by Country USD Million (2023-2028)
  • Table 253. Europe Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 254. Europe Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 255. Europe Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 256. Europe Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 257. Europe Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 258. Germany Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 259. Germany Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 260. Germany Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 261. Germany Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 262. Germany Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 263. France Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 264. France Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 265. France Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 266. France Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 267. France Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 268. Italy Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 269. Italy Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 270. Italy Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 271. Italy Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 272. Italy Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 273. United Kingdom Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 274. United Kingdom Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 275. United Kingdom Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 276. United Kingdom Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 277. United Kingdom Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 278. Netherlands Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 279. Netherlands Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 280. Netherlands Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 281. Netherlands Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 282. Netherlands Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 283. Rest of Europe Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 284. Rest of Europe Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 285. Rest of Europe Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 286. Rest of Europe Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 287. Rest of Europe Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 288. MEA Pulmonary Function Testing Systems, by Country USD Million (2023-2028)
  • Table 289. MEA Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 290. MEA Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 291. MEA Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 292. MEA Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 293. MEA Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 294. Middle East Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 295. Middle East Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 296. Middle East Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 297. Middle East Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 298. Middle East Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 299. Africa Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 300. Africa Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 301. Africa Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 302. Africa Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 303. Africa Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 304. North America Pulmonary Function Testing Systems, by Country USD Million (2023-2028)
  • Table 305. North America Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 306. North America Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 307. North America Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 308. North America Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 309. North America Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 310. United States Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 311. United States Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 312. United States Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 313. United States Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 314. United States Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 315. Canada Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 316. Canada Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 317. Canada Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 318. Canada Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 319. Canada Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 320. Mexico Pulmonary Function Testing Systems, by Type USD Million (2023-2028)
  • Table 321. Mexico Pulmonary Function Testing Systems, by Application USD Million (2023-2028)
  • Table 322. Mexico Pulmonary Function Testing Systems, by Test USD Million (2023-2028)
  • Table 323. Mexico Pulmonary Function Testing Systems, by Component USD Million (2023-2028)
  • Table 324. Mexico Pulmonary Function Testing Systems, by End User USD Million (2023-2028)
  • Table 325. Pulmonary Function Testing Systems: by Type(USD/Units)
  • Table 326. Research Programs/Design for This Report
  • Table 327. Key Data Information from Secondary Sources
  • Table 328. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pulmonary Function Testing Systems: by Type USD Million (2017-2022)
  • Figure 5. Global Pulmonary Function Testing Systems: by Application USD Million (2017-2022)
  • Figure 6. Global Pulmonary Function Testing Systems: by Test USD Million (2017-2022)
  • Figure 7. Global Pulmonary Function Testing Systems: by Component USD Million (2017-2022)
  • Figure 8. Global Pulmonary Function Testing Systems: by End User USD Million (2017-2022)
  • Figure 9. South America Pulmonary Function Testing Systems Share (%), by Country
  • Figure 10. Asia Pacific Pulmonary Function Testing Systems Share (%), by Country
  • Figure 11. Europe Pulmonary Function Testing Systems Share (%), by Country
  • Figure 12. MEA Pulmonary Function Testing Systems Share (%), by Country
  • Figure 13. North America Pulmonary Function Testing Systems Share (%), by Country
  • Figure 14. Global Pulmonary Function Testing Systems: by Type USD/Units (2017-2022)
  • Figure 15. Global Pulmonary Function Testing Systems share by Players 2022 (%)
  • Figure 16. Global Pulmonary Function Testing Systems share by Players (Top 3) 2022(%)
  • Figure 17. Global Pulmonary Function Testing Systems share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. BD (United States) Revenue, Net Income and Gross profit
  • Figure 20. BD (United States) Revenue: by Geography 2022
  • Figure 21. Schiller (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. Schiller (Switzerland) Revenue: by Geography 2022
  • Figure 23. COSMED (Italy) Revenue, Net Income and Gross profit
  • Figure 24. COSMED (Italy) Revenue: by Geography 2022
  • Figure 25. NSpire Health (United States) Revenue, Net Income and Gross profit
  • Figure 26. NSpire Health (United States) Revenue: by Geography 2022
  • Figure 27. Morgan Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Morgan Scientific (United States) Revenue: by Geography 2022
  • Figure 29. Vyaire Medical, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 30. Vyaire Medical, Inc (United States) Revenue: by Geography 2022
  • Figure 31. Medical Equipment Europe GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Medical Equipment Europe GmbH (Germany) Revenue: by Geography 2022
  • Figure 33. ECO MEDICS AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. ECO MEDICS AG (Switzerland) Revenue: by Geography 2022
  • Figure 35. CHEST M.I., Inc (Japan) Revenue, Net Income and Gross profit
  • Figure 36. CHEST M.I., Inc (Japan) Revenue: by Geography 2022
  • Figure 37. Global Pulmonary Function Testing Systems: by Type USD Million (2023-2028)
  • Figure 38. Global Pulmonary Function Testing Systems: by Application USD Million (2023-2028)
  • Figure 39. Global Pulmonary Function Testing Systems: by Test USD Million (2023-2028)
  • Figure 40. Global Pulmonary Function Testing Systems: by Component USD Million (2023-2028)
  • Figure 41. Global Pulmonary Function Testing Systems: by End User USD Million (2023-2028)
  • Figure 42. South America Pulmonary Function Testing Systems Share (%), by Country
  • Figure 43. Asia Pacific Pulmonary Function Testing Systems Share (%), by Country
  • Figure 44. Europe Pulmonary Function Testing Systems Share (%), by Country
  • Figure 45. MEA Pulmonary Function Testing Systems Share (%), by Country
  • Figure 46. North America Pulmonary Function Testing Systems Share (%), by Country
  • Figure 47. Global Pulmonary Function Testing Systems: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • BD (United States)
  • Schiller (Switzerland)
  • COSMED (Italy)
  • nSpire Health (United States)
  • Morgan Scientific (United States)
  • Vyaire Medical, Inc (United States)
  • Medical Equipment Europe GmbH (Germany)
  • ECO MEDICS AG (Switzerland)
  • CHEST M.I., Inc (Japan)
Additional players considered in the study are as follows:
MGC Diagnostics (United States) , Ganshorn (Germany)
Select User Access Type

Key Highlights of Report


Jun 2023 205 Pages 88 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pulmonary Function Testing Systems Quantitative research analysis
Global Pulmonary Function Testing Systems Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Pulmonary Function Testing Systems study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Pulmonary Function Testing Systems Market is gaining popularity and expected to see strong valuation by 2028 .
According to AMA, the Global Pulmonary Function Testing Systems market is expected to see growth rate of xx%.
The Pulmonary Function Testing Systems market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Pulmonary Function Testing Systems Report?

Have a Query? Click Here

Other Related Reports

Pet Dietary Supplement Comprehensive Study by Application (Residential, Commercial), Specialty (Urinary Tract Disease, Diabetes, Renal, Digestive Sensitivity, Oral Care, Other), Form (Soft Gel/Pills,...
$ 3450
Antibody Drug Conjugate Comprehensive Study by Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor), Conjugates (Small Molecules, Protein Toxin, Cytolytic Immunomodula...
$ 3750
Acne Medication Comprehensive Study by Type (Injection, Oral), Application (Hospital, Clinic) Players and Region - Global Market Outlook to 2028
$ 3500
Betamethasone Ointment Comprehensive Study by Type (Betamethasone Dipropionate, Betamethasone Sodium Phosphate, Betamethasone Valerate), Application (Eczema, Dermatitis, Allergies, Rash), Distributio...
$ 3450
Sulfachloropyridazine Sodium Comprehensive Study by Type (Concentration: <10% , Concentration: 10%-20%), Application (Escherichia Coli Infection Treatment , Staphylococcal Infection Treatment), Route...
$ 3750
Clozapine Comprehensive Study by Application (Hospital, Clinic, Home Care), Distribution Channel (Online Retail, Offline Retail), Form (Tablet, Liquid) Players and Region - Global Market Outlook to ...
$ 3500